This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc S.a.. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: The Innovations of Claude Jeanmart in Anti-arrhythmic Compositions
Introduction
Claude Jeanmart is an esteemed inventor based in Brunoy, France. He is recognized for his contributions to the field of pharmacology, particularly in the development of anti-arrhythmic agents. His innovative approach has resulted in a significant patent that highlights new compounds with potential therapeutic benefits.
Latest Patents
Claude Jeanmart holds a notable patent for "Anti-arrhythmic compositions containing isoindoline derivatives." This patent encompasses isoindolin-1-one derivatives that feature a nitrogen atom in the 2-position, which is attached to a phenyl or pyridyl radical. These compounds may carry various substituents including halogen, alkyl (C1-C4), alkoxy (C1-C4), cyano, and trifluoromethyl. In the 3-position, the compounds include a grouping of --O--T--NR1R2, where T is an alkylene chain (C2-C6), and R1 and R2 can either be hydrogen or alkyl (C1-C4). These innovative compounds are distinguished by their pharmacodynamic properties and their efficacy as anti-arrhythmic agents.
Career Highlights
Claude Jeanmart has made significant strides in his career, which is punctuated by his role at Rhône-Poulenc S.A., a company known for its dedication to pharmaceutical research and innovation. His work has contributed to advancing the understanding of anti-arrhythmic treatments and their applications.
Collaborations
Throughout his career, Claude Jeanmart has collaborated with several notable individuals, including Claude Cotrel and Mayer Naoum Messer. These partnerships have enabled the exchange of ideas and fostered innovation in the development of their projects, particularly in the realm of pharmacological research.
Conclusion
Claude Jeanmart's innovations, particularly in the formulation of anti-arrhythmic compositions, showcase the vital role that inventors play in advancing medical science. His patent reflects a commitment to improving health outcomes through innovative chemistry and collaboration. As research continues, the compounds developed under his guidance may pave the way for more effective treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile